Literature DB >> 10421648

Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis.

O Isokawa1, T Suda, Y Aoyagi, H Kawai, T Yokota, T Takahashi, K Tsukada, T Shimizu, S Mori, Y Abe, Y Suzuki, M Nomoto, Y Mita, M Yanagi, H Igarashi, H Asakura.   

Abstract

Hepatocellular carcinoma (HCC) mainly arises from the liver with chronic inflammation. Because telomere reduction reflects replicative history in somatic cells, we analyzed the possibility that liver tissues surrounding HCC consist of the cells carrying substantial reduction of telomere. We studied 20 HCC and surrounding noncancerous liver tissues (SL) obtained by surgical resection, and 10 laparoscopically obtained needle biopsy specimens of the liver with chronic inflammation including no overt HCC (CI). Five liver tissues without chronic liver diseases (ND) were also examined. Extracted genomic DNAs were blotted on a nylon membrane, and probed at first with radio-labeled d(TTAGGG)(3) and reprobed with radio-labeled d(CCT)(7). The intensity caused by d(TTAGGG)(3) was divided by that of d(CCT)(7). The ratio was defined as telomeric repeats content (TC). Dilution experiments reproducibly revealed almost the same TC. The reduction rate of telomere length through aging estimated by regression analysis of TC was 0.62% per year. Concomitant analyses of TC and average telomere length revealed that both values were significantly correlated (r =.45; P =.009). To compare TC in the liver with respect to chronic inflammation, the value was divided by TC in peripheral blood leukocytes (PBL) from the same donor. The ratio was defined as relative TC (RTC). There was a statistically significant decrease of RTC in CI compared with that in ND (P =.03). Furthermore, RTC in SL was significantly lower than that in CI (P =.0001). These observations suggest that RTC value in liver tissues may digitally indicate a replicative history of hepatocytes under chronic inflammation, and a risk of HCC development.

Entities:  

Mesh:

Year:  1999        PMID: 10421648     DOI: 10.1002/hep.510300211

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Hepatocellular telomere length in biliary atresia measured by Q-FISH.

Authors:  Yukihiro Sanada; Junko Aida; Youichi Kawano; Ken-ichi Nakamura; Naotaka Shimomura; Naoshi Ishikawa; Tomio Arai; Steven S S Poon; Naoya Yamada; Noriki Okada; Taiichi Wakiya; Makoto Hayashida; Takeshi Saito; Satoshi Egami; Shuji Hishikawa; Yoshiyuki Ihara; Taizen Urahashi; Koichi Mizuta; Yoshikazu Yasuda; Hideo Kawarasaki; Kaiyo Takubo
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

Review 2.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

3.  Clinical characteristics of hepatocellular carcinoma in elderly patients.

Authors:  Takuya Honda; Hisamitsu Miyaaki; Tatsuki Ichikawa; Naota Taura; Satoshi Miuma; Hidetaka Shibata; Hajime Isomoto; Fuminao Takeshima; Kazuhiko Nakao
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

Review 4.  A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.

Authors:  Eunae Cho; Hyun A Cho; Chung Hwan Jun; Hee Joon Kim; Sung Bum Cho; Sung Kyu Choi
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

5.  Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.

Authors:  Bong-Kyeong Oh; Young-Joo Kim; Chanil Park; Young Nyun Park
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Authors:  Hua Yang; Fu Xia Xiong; Ming Lin; Yu Yang; Xiu Nie; Rou Li Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-19       Impact factor: 4.553

7.  Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma.

Authors:  Daiki Miki; Hiroshi Aikata; Kiminori Uka; Hiromi Saneto; Tomokazu Kawaoka; Takahiro Azakami; Shintaro Takaki; Soo Cheol Jeong; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Toshiyuki Itamoto; Toshimasa Asahara; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 8.  Treatment for hepatocellular carcinoma in elderly patients: a literature review.

Authors:  Hiroki Nishikawa; Toru Kimura; Ryuichi Kita; Yukio Osaki
Journal:  J Cancer       Date:  2013-09-14       Impact factor: 4.207

9.  Chemoprevention of gastrointestinal cancer: the reality and the dream.

Authors:  Kyung-Soo Chun; Eun-Hee Kim; Sooyeon Lee; Ki Baik Hahm
Journal:  Gut Liver       Date:  2013-02-07       Impact factor: 4.519

Review 10.  Hepatocellular carcinoma in elderly patients: challenges and solutions.

Authors:  Angélique Brunot; Samuel Le Sourd; Marc Pracht; Julien Edeline
Journal:  J Hepatocell Carcinoma       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.